2016 International Congress Archives - Page 54 of 207

Bacterial biofilm formation on neurostimulation systems

A. Wloch, B. Hong, M. Abdallat, A. Winkel, A. Saryyeva, G. Lütjens, M. Stiesch, J.K. Krauss (Hannover, Germany)
Balance and gait disturbances in Parkinson’s disease patients with falls and freezing of gait

J. Stozek, M. Rudzinska, S. Bukowczan, A. Szczudlik (Cracow, Poland)
Balance in patients with newly diagnosed Parkinson´s disease – A three year follow-up of a cohort in Northern Sweden

C. Johansson, E. Johansson, G.M. Johansson, B. Lindström, L. Forsgren (Sävar, Sweden)
Balance training in individual’s with Parkinson’s disease: Therapist-supervised vs. home-based exercise programmes

E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)
Barriers to providing quality care for people with Parkinson’s living in care homes in the UK: The role of staff training

L.L. Oates, A. Hand, R.W. Walker, W.K. Gray (North Shields, United Kingdom)
Baseline physical activity may influence exercise-induced changes in cognitive function in Parkinson’s disease

R. Chow, C.R.A. Silveira, B.N. Intzandt, E. Beck, Q.J. Almeida (Waterloo, ON, Canada)
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort

T. Simuni, D. Weintraub, C. Caspell-Garcia, M. Walker, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)
Bcr-Abl tyrosine-kinase inhibitors (B-ATKI) and Parkinson’s disease (PD)

E.A. Shamim, S.F. Baker, F.F. Liu, K.K. Mane, J.G. Layug, S. Vupputuri, C.C. DiStasio, S.M. Khandhar, C. Neff, S. Van Den Eeden, C. Lungu, R. Cooley, H.S. Martel, C. Chen, J. Dorman, M.A. Sinkiewicz, J. Klingman (Largo, MD, USA)
Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease

F. Schaible, F. Schwartz, T. v. Eimeren, C. Eggers (Köln, Germany)
Beliefs and knowledge on Parkinson’s disease (PD) among people with PD, the public and traditional healers in Western Cape, South Africa

J. Mokaya, J. Carr (Tygerberg, South Africa)
Beneficial effect of L-theanine against 3-nitropropionic acid induced neurotoxicity in rats: Possible role of neurotransmitters and nitric oxide

P. Kumar, S. Jamwal (Moga, India)
Best supportive care or palliative care for late stage Parkinsonian syndromes?

S. Lorenzl, C. Richinger, C. Schmotz, G. Nübling (Salzburg, Austria)
Beta – blockers worsen vascular parkinsonism in patients with concomitant coronary heart disease

A. Turakhonov, S. Dadajonov, R. Sadikov, R. Khodjaev, S. Nurov (Tashkent, Uzbekistan)
Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients

A. Romagnolo, M.G. Rizzone, F. Dematteis, M. Zibetti, A. Merola, L. Rizzi, E. Montanaro, C.A. Artusi, M. Lanotte, L. Lopiano (Turin, Italy)
Beyond initial clinical phenotype of Madelung disease: Myoclonus, gait disorder and multisystem involvement led to genetic diagnosis

R. López-Blanco, A. Rojo-Sebastián, M.H. Torregrosa-Martínez, M. Molina-Sánchez, A. Blázquez-Encinar, M.Á. Martín-Casanueva (Madrid, Spain)
Bi-hemispheric phase synchronization in patients with Parkinson’s disease during stance, gait and upper limb motor tasks

M. Plotnik, Y. Miron, S. Hassin-Baer, O.S. Cohen, S. Kimel-Naor, I. Blatt, R. Inzelberg, J.W. Kantelhardt (Tel Hashomer, Israel)
Bilateral subthalamic nucleus deep-brain stimulation (STN-DBS) in the management of idiopathic Parkinson’s disease: Results of our first 20 cases

E.M. Rezk, A.A.E. Shakal, S.M. Tourky (Tanta-Gharbeya, Egypt)
Bing-Neel syndrome presenting with Parkinsonian features: A case report

P.M. Barbosa, S. D'Sa, K.M. Ardeshna, J. Rees, A.J. Lees, T.T. Warner (London, United Kingdom)
Biochemical evaluation in patients with suspected ataxia related to CoQ10 deficiency

J.L.H. Pedroso, F.G. Ravagnani, M.H. Barros, L.R. Sanches, F.R. Picosse, T.O. Lopes, P.C. Aguiar, M. Chiaratti, C.H. Macabelli, J.H. Arita, M.R. Masruha, O.G. Barsottini, C.C. Ferreiro-Barros (Sao Paulo, Brazil)
Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)
Biseptol a new antiParkinsonian agent?

K. Karpinska, V. Smolanka (Uzhgorod, Ukraine)
Blinded video assessment of subtle Parkinsonian signs in PREDICT-PD participants

A.J. Noyce, A. Schrag, J. Masters, J.P. Bestwick, G. Giovannoni, A.J. Lees (London, United Kingdom)
Blindfolded balance training in patients with Parkinson’s disease: A sensory-motor strategy to improve the gait

A. Peppe, S. Bonnì, M. Fabio, K. Giacomo, A. Martino Cinnera, M. Tramontano, C. Caltagirone (Rome, Italy)
Blunted perception of respiratory resistive loads in Parkinson’s disease

K.W. Hegland, M.S. Troche, M.S. Okun, A.E. Brandimore (Gainesville, FL, USA)
Body position during sleep in patients with Parkinson’s disease (PD): A sensor-based analysis

J. Sringean, P. Taechalertpaisarn, C. Thanawattano, R. Bhidayasiri (Nonthaburi, Thailand)
Body weight determinants in Parkinson’s disease: A multifactorial study

A. Bril, M. Rossi, S. Fariña, P. Morisset, L. Sorrentino, M. Iglesias, A. Medina Escobar, P. Millar Vernetti, D. Cerquetti, S. Perez Lloret, M. Merello (Buenos Aires, Argentina)
Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

F.B. Rodrigues, G.S. Duarte, R.E. Marques, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)
Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update

M. Castelão, F.B. Rodrigues, R.E. Marques, G.S. Duarte, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)
Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

M. Castelão, G.S. Duarte, F.B. Rodrigues, R.E. Marques, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)
Botulinum toxin A injections changes sensorimotor network activations in cervical dystonia to state more related to physiological condition

M. Nevrly, P. Hlustik, P. Otruba, P. Hok, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)
Botulinum toxin in cerebral palsy children with gait disorder: Different therapy approaches

G.S. Pilina (Izhevsk, Russia)
Botulinum toxin treatment of freezing of gait in Parkinson’s disease patients as reflected in functional magnetic resonance imaging of leg movement

M. Vaštík, P. Hok, P. Hluštík, P. Kanovský, Z. Tüdös (Olomouc, Czech Republic)
Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis

R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)
Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis

R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)
Bradykinesia of external urethral sphincter in a Patient with Parkinson’s disease: Case report

I.E. Estrada-Bellmann, A. Gutierrez, H.J. Villarreal, J.J. Peña, D. Ortiz (Monterrey, Mexico)
Bradykinesia, low monthly income and current employment are associated with depression in patients with Parkinson’s disease: Results of a study from Sri Lanka

M.R. Withana, T.B. Herath, C. Rodrigo, C. Gamage, R. Gamage (Colombo, Sri Lanka)
Brain iron levels in Parkinson’s disease by postmortem and MRI measurements: A systematic review and meta-analysis

J.Y. Wang, Q.Q. Zhuang, L.B. Zhu, H. Zhu, T. Li, X. Zhang, J.H. Zhu (Wenzhou, People's Republic of China)
Brain mechanisms underlying visual processing in Parkinson’s disease

I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)
Brain metabolic profile changes reflect subtle pathological alterations in different murine models of Parkinson’s disease

E. Glaab, F. Giesert, C. Jaeger, P. Dirscherl, A. Zimprich, A. Ulusoy, D.A. Di Monte, P. Garcia, R. Balling, W. Wurst, D. Truembach, M. Buttini, D. Vogt-Weisenhorn (Esch-Alzette, Luxembourg)
Brain network imaging findings in multiple system atrophy with cognitive decline

K. Hara, H. Watanabe, E. Bagarinao, K. Kawabata, N. Yoneyama, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)
Brain networks revealed by resting state functional MRI in familial and sporadic primary dystonia

K. Fujita, A. Vo, D. Eidelberg (Manhasset, NY, USA)
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment

E. Fiorenzato, R. Biundo, L. Weis, K. Seppi, M. Onofrj, P. Cortelli, H. Kaufmann, W. Poewe, F. Krismer, G. Wenning, A. Antonini (Venice-Lido, Italy)
Bristle hair may point to hereditary spastic paraplegia type SPG35/ FAHN

T.W. Rattay, A.S. Söhn, K.N. Karle, S. Wiethoff, J. Reichbauer, M. Döbler-Neumann, I. Krägeloh-Mann, A. Münchau, B. Wilken, P. Bauer, L. Schöls, R. Schüle (Tübingen, Germany)
Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument

Y. Xin, J. Lewsey, R. Gray, C.E. Clarke, E. McIntosh (Glasgow, United Kingdom)
Burden of movement disorders in Cameroon: In/out patient population study

J.N. Doumbe, Y. Mapoure, E. Cubo, T. Nyinyikua, K. Kompoliti (Douala, Cameroon)